Prostacyclin works better than a common heart medication called glyceryl trinitrate to relax veins that have been tightened by another substance, making the veins open up more — it reduces tightening to just 12% instead of 33%.
Claim Language
Language Strength
definitive
Uses definitive language (causes, prevents, cures)
The claim uses definitive language such as 'is more effective than', 'reducing', and 'suggesting superior potency', which assert a clear, direct comparison and outcome without hedging. These phrases imply a causal or deterministic relationship rather than probabilistic or associative ones.
Context Details
Domain
medicine
Population
human
Subject
Prostacyclin
Action
is more effective than
Target
nitric oxide (administered as glyceryl trinitrate) at inhibiting endothelin-1-induced venoconstriction in human veins, reducing maximal constriction to 12 ± 3% compared to 33 ± 5%
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Endothelium-dependent modulation of responses to endothelin-I in human veins.
Scientists tested two drugs—prostacyclin and glyceryl trinitrate—on human veins to see which one stops a tightening reaction better. Prostacyclin worked much better, reducing the tightening to just 12% compared to 33% with the other drug, so yes, it’s stronger at relaxing veins in this case.